In Brief: Searle Covera-HS
Searle Covera-HS: Controlled-release once-daily verapamil, approved Feb. 26 for hypertension and angina with bedtime dosing, will be available as of April 29 ("The Pink Sheet" March 4, T&G-7). AWP for the calcium channel blocker will be $106.80 for 100 180 mg tabs and $146.40 for 100 240 mg tabs, according to Medi-Span's Prescription Drug Price Supplement...
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth